Bovine lactoferrin digested with human gastrointestinal enzymes inhibits replication of human echovirus 5 in cell culture

Nutrition Research

Volumn 32, Issue 7, 2012, Pages 503-513

  Furlund, Camilla B ^a,b,c   Kristoffersen, Anja B ^c   Devold, Tove G ^a   Vegarud, Gerd E ^a   Jonassen, Christine M ^b,c  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN VETERINARY INSTITUTE   (Norway)

Author keywords

Bovine lactoferrin; Caco 2 cells; Echovirus 5; Human gastrointestinal enzymes; In vitro digestion; Viral inhibition

Indexed keywords

INTESTINE ENZYME; LACTOFERRIN; PEPTIDE;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DIGESTION; DUODENUM FLUID; ECHO VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN ECHOVIRUS 5; IN VITRO STUDY; INFANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; STOMACH JUICE; STOMACH PH; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CACO-2 CELLS; CATTLE; ENTEROVIRUS B, HUMAN; GASTRIC JUICE; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; INFANT FORMULA; LACTOFERRIN; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

BOVINAE; ENTEROVIRUS; HUMAN ECHOVIRUS 5;

EID: 84865186840     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.06.006     Document Type: Article

References (71)

1. FAO/WHO [Food and Agriculture Organization of the United Nations/World Healt Organization]. Viruses in Food: Scientific advice to support risk management activities. Microbiological risk assessment series no. 13. Rome. The Organization; 2008:1-79.
2. Fong T.T., Lipp E.K. Enteric viruses of humans and animals in aquatic environments: health risks, detection, and potential water quality assessment tools. Microbiol Mol Biol Rev 2005, 69(2):357-371.
3. Greening G.E. Human and animal viruses in food (including taxonomy of enteric viruses). Viruses in food 2006, 5-42. Springer, New York. S.M. Goyal (Ed.).
4. Wyn-Jones A.P., Sellwood J. Enteric viruses in the aquatic environment. J Appl Microbiol 2001, 91(6):945-962.
5. Koopmans M., Duizer E. Foodborne viruses: an emerging problem. Int J Food Microbiol 2004, 90(1):23-41.
6. Nwachuku N., Gerba C.P. Health risks of enteric viral infections in children. Rev Environ Contam Toxicol 2006, 186:1-56.
7. Pallansch M., Roos R. Enteroviruses: polioviruses, coxackieviruses, echoviruses, and newer enteroviruses. Fields virology 2006, 839-893. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
8. Jenista J.A., Powell K.R., Menegus M.A. Epidemiology of neonatal enterovirus infection. J Pediatr 1984, 104(5):685-690.
9. Jenista J.A., Menegus M.A. Neonatal enterovirus infection. Indian J Pediatr 1988, 55(2):191-196.
10. Witso E., Cinek O., Aldrin M., Grinde B., Rasmussen T., Wetlesen T., et al. Predictors of sub-clinical enterovirus infections in infants: a prospective cohort study. Int J Epidemiol 2010, 39(2):459-468.
11. Seganti L., Di Biase A.M., Marchetti M., Pietrantoni A., Tinari A., Superti F. Antiviral activity of lactoferrin towards naked viruses. Biometals 2004, 17(3):295-299.
12. Gonzalez-Chavez S.A., Arevalo-Gallegos S., Rascon-Cruz Q. Lactoferrin: structure, function and applications. Int J Antimicrob Agents 2009, 33(4):301-308.
13. Levay P.F., Viljoen M. Lactoferrin: a general review. Haematologica 1995, 80(3):252-267.
14. van der Strate B.W., Beljaars L., Molema G., Harmsen M.C., Meijer D.K. Antiviral activities of lactoferrin. Antiviral Res 2001, 52(3):225-239.
15. Suzuki Y.A., Lopez V., Lonnerdal B. Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci 2005, 62(22):2560-2575.
16. Harmsen M.C., Swart P.J., Debethune M.P., Pauwels R., Declercq E., The T.H., et al. Antiviral effects of plasma and milk-proteins-lactoferrin shows potent activity against both human-immunodeficiency-virus and human cytomegalovirus replication in-vitro. J Infect Dis 1995, 172(2):380-388.
17. Hasegawa K., Motsuchi W., Tanaka S., Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn J Med Sci Biol 1994, 47(2):73-85.
18. Swart P.J., Kuipers M.E., Smit C., Pauwels R., Debethune M.P., De C.E., et al. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res Hum Retroviruses 1996, 12(9):769-775.
19. Weng T.Y., Chen L.C., Shyu H.W., Chen S.H., Wang J.R., Yu C.K., et al. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antiviral Res 2005, 67(1):31-37.
20. Ikeda M., Nozaki A., Sugiyama K., Tanaka T., Naganuma A., Tanaka K., et al. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res 2000, 66(1):51-63.
21. Pietrantoni A., Ammendolia M.G., Tinari A., Siciliano R., Valenti P., Superti F. Bovine lactoferrin peptidic fragments involved in inhibition of echovirus 6 in vitro infection. Antiviral Res 2006, 69(2):98-106.
22. Superti F., Ammendolia M.G., Valenti P., Seganti L. Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med Microbiol Immunol 1997, 186(2-3):83-91.
23. Ammendolia M.G., Marchetti M., Superti F. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in green monkey kidney cells. Antiviral Res 2007, 76(3):252-262.
24. Beljaars L., van der Strate B.W.A., Bakker H.I., Reker-Smit C., van Loenen-Weemaes A.M., Wiegmans F.C., et al. Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo. Antiviral Res 2004, 63(3):197-208.
25. Chatterton D.E.W., Rasmussen J.T., Heegaard C.W., Sorensen E.S., Petersen T.E. In vitro digestion of novel milk protein ingredients for use in infant formulas: research on biological functions. Trends Food Sci Technol 2004, 15(7-8):373-383.
26. Sanchez L., Calvo M., Brock J.H. Biological role of lactoferrin. Arch Dis Child 1992, 67(5):657-661.
27. Chabance B., Marteau P., Rambaud J.C., Migliore-Samour D., Boynard M., Perrotin P., et al. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 1998, 80(2):155-165.
28. Troost F.J., Steijns J., Saris W.H., Brummer R.J. Gastric digestion of bovine lactoferrin in vivo in adults. J Nutr 2001, 131(8):2101-2104.
29. Dunn B.M. Structure and mechanism of the pepsin-like family of aspartic peptidases. Chem Rev 2002, 102(12):4431-4458.
30. Ekmekcioglu C. A physiological approach for preparing and conducting intestinal bioavailability studies using experimental systems. Food Chem 2002, 76(2):225-230.
31. Scheele G., Bartelt D., Bieger W. Characterization of human exocrine pancreatic proteins by two-dimensional isoelectric focusing/sodium dodecyl sulfate gel electrophoresis. Gastroenterology 1981, 80(3):461-473.
32. Dressman J.B., Berardi R.R., Dermentzoglou L.C., Russell T.L., Schmaltz S.P., Barnett J.L., et al. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res 1990, 7(7):756-761.
33. Kalantzi L., Goumas K., Kalioras V., Abrahamsson B., Dressman J.B., Reppas C. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 2006, 23(1):165-176.
34. Ulleberg E.K., Comi I., Holm H., Herud E.B., Jacobsen M., Vegarud G.E. Human gastrointestinal juices intended for use in in vitro digestion models. Food Dig 2011, 2(2):52-61.
35. Amiot J., Germain L., Turgeon S., Lemay M., Ory-Salam C., Auger F.A. Peptides from milk protein hydrolysates to improve the growth of human keratinocytes in culture. Int Dairy J 2004, 14(7):619-626.
36. Bordenave S., Sannier F., Ricart G., Piot J.M. Characterization of a goat whey peptic hydrolysate produced by an ultrafiltration membrane enzymic reactor. J Dairy Res 2000, 67(4):551-559.
37. Hernández-Ledesma B., Quirós A., Amigo L., Recio I. Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin. Int Dairy J 2007, 17(1):42-49.
38. Kim S.B., Ki K.S., Khan M.A., Lee W.S., Lee H.J., Ahn B.S., et al. Peptic and tryptic hydrolysis of native and heated whey protein to reduce its antigenicity. J Dairy Sci 2007, 90(9):4043-4050.
39. Almaas H., Holm H., Langsrud T., Flengsrud R., Vegarud G.E. In vitro studies of the digestion of caprine whey proteins by human gastric and duodenal juice and the effects on selected microorganisms. Br J Nutr 2006, 96(3):562-569.
40. Eriksen E.K., Holm H., Jensen E., Aaboe R., Devold T.G., Jacobsen M., et al. Different digestion of caprine whey proteins by human and porcine gastrointestinal enzymes. Br J Nutr 2010, 374-381.
41. Almaas H., Eriksen E., Sekse C., Comi I., Flengsrud R., Holm H., et al. Antibacterial peptides derived from caprine whey proteins, by digestion with human gastrointestinal juice. Br J Nutr 2011, 106(6):896-905.
42. Jiménez-Clavero M.-A., Ley V., Gómez N., Sáiz J.-C. Detection of enteroviruses. Food-borne pathogens: methods and protocols 2006, 153-170. Human Press Inc., Totowa. C.C. Adley (Ed.).
43. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1983, 27(3):493-497.
44. Laemmli U.K. Cleavage of structural proteins during assembly of head of bacteriophage-T4. Nature 1970, 227(5259):680-685.
45. Verstrepen W.A., Bruynseels P., Mertens A.H. Evaluation of a rapid real-time RT-PCR assay for detection of enterovirus RNA in cerebrospinal fluid specimens. J Clin Virol 2002, 25(Suppl. 1):S39-S43.
46. Rotbart H.A. Diagnosis of enteroviral meningitis with the polymerase chain reaction. J Pediatr 1990, 117(1 Pt 1):85-89.
47. Watkins-Riedel T., Woegerbauer M., Hollemann D., Hufnagl P. Rapid diagnosis of enterovirus infections by real-time PCR on the LightCycler using the TaqMan format. Diagn Microbiol Infect Dis 2002, 42(2):99-105.
48. Fallingborg J., Christensen L.A., Ingeman-Nielsen M., Jacobsen B.A., Abildgaard K., Rasmussen H.H., et al. Measurement of gastrointestinal pH and regional transit times in normal children. J Pediatr Gastroenterol Nutr 1990, 11(2):211-214.
49. Fallingborg J., Christensen L.A., Ingeman-Nielsen M., Jacobsen B.A., Abildgaard K., Rasmussen H.H., et al. Gastrointestinal pH and transit times in healthy subjects with ileostomy. Aliment Pharmacol Ther 1990, 4(3):247-253.
50. Fallingborg J. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull 1999, 46(3):183-196.
51. Kaye J.L. Review of paediatric gastrointestinal physiology data relevant to oral drug delivery. Int J Clin Pharmacy 2011, 33(1):20-24.
52. Troost F.J., Saris W.H.M., Brummer R.J.M. Orally ingested human lactoferrin is digested and secreted in the upper gastrointestinal tract in vivo in women with ileostomies. J Nutr 2002, 132(9):2597-2600.
53. Puddu P., Valenti P., Gessani S. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie 2009, 91(1):11-18.
54. Li D., Sakashita S., Morishita Y., Kano J., Shiba A., Sato T., et al. Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line. Anticancer Res 2011, 31(2):529-534.
55. Wolf J.S., Li G., Varadhachary A., Petrak K., Schneyer M., Li D., et al. Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clin Cancer Res 2007, 13(5):1601-1610.
56. Ji Z.S., Mahley R.W. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler Thromb 1994, 14(12):2025-2031.
57. Suzuki Y.A., Lonnerdal B. Characterization of mammalian receptors for lactoferrin. Biochem Cell Biol-Biochim Biol Cell 2002, 80(1):75-80.
58. Lonnerdal B., Jiang R., Du X. Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities. J Pediatr Gastroenterol Nutr 2011, 53(6):606-614.
59. Goodfellow I.G., Sioofy A.B., Powell R.M., Evans D.J. Echoviruses bind heparan sulfate at the cell surface. J Virol 2001, 75(10):4918-4921.
60. Israelsson S., Gullberg M., Jonsson N., Roivainen M., Edman K., Lindberg A.M. Studies of echovirus 5 interactions with the cell surface: heparan sulfate mediates attachment to the host cell. Virus Res 2010, 151(2):170-176.
61. Salmivirta M., Safaiyan F., Prydz K., Andresen M.S., Aryan M., Kolset S.O. Differentiation-associated modulation of heparan sulfate structure and function in CaCo-2 colon carcinoma cells. Glycobiology 1998, 8(10):1029-1036.
62. Heinz B.A., Cliver D.O. Coxsackievirus-cell interactions that initiate infection in porcine ileal explants. Arch Virol 1988, 101(1-2):35-47.
63. Ouzilou L., Caliot E., Pelletier I., Prevost M.C., Pringault E., Colbere-Garapin F. Poliovirus transcytosis through M-like cells. J Gen Virol 2002, 83(Pt 9):2177-2182.
64. Yanagishita M., Hascall V.C. Cell surface heparan sulfate proteoglycans. J Biol Chem 1992, 267(14):9451-9454.
65. Marchetti M., Superti F., Ammendolia M.G., Rossi P., Valenti P., Seganti L. Inhibition of poliovirus type 1 infection by iron-, manganese and zinc-saturated lactoferrin. Med Microbiol Immunol 1999, 187(4):199-204.
66. Mccann K.B., Lee A., Wan J., Roginski H., Coventry M.J. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J Appl Microbiol 2003, 95(5):1026-1033.
67. Andersen J.H., Osbakk S.A., Vorland L.H., Traavik T., Gutteberg T.J. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 2001, 51(2):141-149.
68. Andersen J.H., Jenssen H., Sandvik K., Gutteberg T.J. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J Med Virol 2004, 74(2):262-271.
69. Jenssen H., Sandvik K., Andersen J.H., Hancock R.E.W., Gutteberg T.J. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin. Antiviral Res 2008, 79(3):192-198.
70. Marr A.K., Jenssen H., Moniri M.R., Hancock R.E.W., Pante N. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of herpes simplex virus-1. Biochimie 2009, 91(1):160-164.
71. Mistry N., Drobni P., Naslund J., Sunkari V.G., Jenssen H., Evander M. The anti-papillomavirus activity of human and bovine lactoferricin. Antiviral Res 2007, 75(3):258-265.